nodes	percent_of_prediction	percent_of_DWPC	metapath
Natamycin—Corneal opacity—Tretinoin—peripheral nervous system neoplasm	0.137	0.137	CcSEcCtD
Natamycin—Corneal opacity—Isotretinoin—peripheral nervous system neoplasm	0.137	0.137	CcSEcCtD
Natamycin—Corneal opacity—Alitretinoin—peripheral nervous system neoplasm	0.104	0.104	CcSEcCtD
Natamycin—Eye irritation—Tretinoin—peripheral nervous system neoplasm	0.0419	0.0419	CcSEcCtD
Natamycin—Eye irritation—Isotretinoin—peripheral nervous system neoplasm	0.0419	0.0419	CcSEcCtD
Natamycin—Lacrimation increased—Tretinoin—peripheral nervous system neoplasm	0.0389	0.0389	CcSEcCtD
Natamycin—Lacrimation increased—Isotretinoin—peripheral nervous system neoplasm	0.0389	0.0389	CcSEcCtD
Natamycin—Eye irritation—Alitretinoin—peripheral nervous system neoplasm	0.0318	0.0318	CcSEcCtD
Natamycin—Lacrimation increased—Alitretinoin—peripheral nervous system neoplasm	0.0295	0.0295	CcSEcCtD
Natamycin—Lacrimation—Epirubicin—peripheral nervous system neoplasm	0.0202	0.0202	CcSEcCtD
Natamycin—Lacrimation—Doxorubicin—peripheral nervous system neoplasm	0.0187	0.0187	CcSEcCtD
Natamycin—Chest pain—Topotecan—peripheral nervous system neoplasm	0.0134	0.0134	CcSEcCtD
Natamycin—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.0133	0.0133	CcSEcCtD
Natamycin—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.0133	0.0133	CcSEcCtD
Natamycin—Chest pain—Melphalan—peripheral nervous system neoplasm	0.0132	0.0132	CcSEcCtD
Natamycin—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.0129	0.0129	CcSEcCtD
Natamycin—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.0119	0.0119	CcSEcCtD
Natamycin—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.0116	0.0116	CcSEcCtD
Natamycin—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.0115	0.0115	CcSEcCtD
Natamycin—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.0115	0.0115	CcSEcCtD
Natamycin—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.0115	0.0115	CcSEcCtD
Natamycin—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.0114	0.0114	CcSEcCtD
Natamycin—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.0114	0.0114	CcSEcCtD
Natamycin—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.0113	0.0113	CcSEcCtD
Natamycin—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.0112	0.0112	CcSEcCtD
Natamycin—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.0101	0.0101	CcSEcCtD
Natamycin—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.00955	0.00955	CcSEcCtD
Natamycin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00949	0.00949	CcSEcCtD
Natamycin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00941	0.00941	CcSEcCtD
Natamycin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00941	0.00941	CcSEcCtD
Natamycin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00929	0.00929	CcSEcCtD
Natamycin—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.00884	0.00884	CcSEcCtD
Natamycin—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.0087	0.0087	CcSEcCtD
Natamycin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00863	0.00863	CcSEcCtD
Natamycin—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00838	0.00838	CcSEcCtD
Natamycin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00789	0.00789	CcSEcCtD
Natamycin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00769	0.00769	CcSEcCtD
Natamycin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00741	0.00741	CcSEcCtD
Natamycin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00736	0.00736	CcSEcCtD
Natamycin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00713	0.00713	CcSEcCtD
Natamycin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00687	0.00687	CcSEcCtD
Natamycin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00679	0.00679	CcSEcCtD
Natamycin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00674	0.00674	CcSEcCtD
Natamycin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00608	0.00608	CcSEcCtD
Natamycin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00557	0.00557	CcSEcCtD
Natamycin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00442	0.00442	CcSEcCtD
Natamycin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00409	0.00409	CcSEcCtD
Natamycin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Natamycin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00378	0.00378	CcSEcCtD
Natamycin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00352	0.00352	CcSEcCtD
Natamycin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.0035	0.0035	CcSEcCtD
Natamycin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00312	0.00312	CcSEcCtD
Natamycin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00289	0.00289	CcSEcCtD
